Clinical and immunologic characteristics in peripartum cardiomyopathy

International Journal of Cardiology

Volumn 118, Issue 1, 2007, Pages 14-20

  Lamparter, Steffen ^a   Pankuweit, Sabine ^b   Maisch, Bernhard ^b  

^a Diakonie Krankenhaus Wehrda   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Dilated cardiomyopathy; Myocarditis; Pericarditis; Peripartum cardiomyopathy; Pregnancy

Indexed keywords

AUTOANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MYOCARDITIS; PATHOGENESIS; PERIPARTUM CARDIOMYOPATHY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE;

ADULT; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; MYOCARDITIS; PERICARDITIS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PUERPERAL DISORDERS; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 34047118550     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.04.090     Document Type: Article

References (46)

1. Pearson G.D., Veille J.C., Rahimtoola S., et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283 9 (2000) 1183-1188
2. Melvin K.R., Richardson P.J., Olsen E.G., Daly K., and Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med 307 12 (1982) 731-734
3. Midei M.G., DeMent S.H., Feldman A.M., Hutchins G.M., and Baughman K.L. Peripartum myocarditis and cardiomyopathy. Circulation 81 3 (1990) 922-928
4. Rizeq M.N., Rickenbacher P.R., Fowler M.B., and Billingham M.E. Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 74 5 (1994) 474-477
5. Gottdiener J.S., Bednarz J., Devereux R., et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17 10 (2004) 1086-1119
6. Aretz H.T., Billingham M.E., Edwards W.D., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1 1 (1987) 3-14
7. Pankuweit S., Hufnagel G., Eckhardt H., Herrmann H., Uttecht S., and Maisch B. Cardiotropic DNA viruses and bacteria in the pathogenesis of dilated cardiomyopathy with or without inflammation. Med Klin (Munich) 93 4 (1998) 223-228
8. Maisch B., Bauer E., Cirsi M., and Kochsiek K. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance. Circulation 87 5 Suppl (1993) IV49-IV65
9. Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93 5 (1996) 841-842
10. Pankuweit S., Portig I., Lottspeich F., and Maisch B. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 29 1 (1997) 77-84
11. Fett J.D., Carraway R.D., Dowell D.L., King M.E., and Pierre R. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 186 5 (2002) 1005-1010
12. Seftel H., and Susser M. Maternity and myocardial failure in African women. Br Heart J 23 (1961) 43-52
13. Mehta N.J., Mehta R.N., and Khan I.A. Peripartum cardiomyopathy: clinical and therapeutic aspects. Angiology 52 11 (2001) 759-762
14. Ro A., and Frishman W.H. Peripartum cardiomyopathy. Cardiol Rev 14 1 (2006) 35-42
15. Cenac A., Tourmen Y., Adehossi E., Couchouron N., Djibo A., and Abgrall J.F. The duo low plasma NT-PRO-BRAIN natriuretic peptide and C-reactive protein indicates a complete remission of peripartum cardiomyopathy. Int J Cardiol 108 2 (2006) 269-270
16. Geva T., Mauer M.B., Striker L., Kirshon B., and Pivarnik J.M. Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J 133 1 (1997) 53-59
17. Mone S.M., Sanders S.P., and Colan S.D. Control mechanisms for physiological hypertrophy of pregnancy. Circulation 94 4 (1996) 667-672
18. Demakis J.G., Rahimtoola S.H., Sutton G.C., et al. Natural course of peripartum cardiomyopathy. Circulation 44 6 (1971) 1053-1061
19. Demakis J.G., and Rahimtoola S.H. Peripartum cardiomyopathy. Circulation 44 5 (1971) 964-968
20. Ravikishore A.G., Kaul U.A., Sethi K.K., and Khalilullah M. Peripartum cardiomyopathy: prognostic variables at initial evaluation. Int J Cardiol 32 3 (1991) 377-380
21. Lampert M.B., Hibbard J., Weinert L., Briller J., Lindheimer M., and Lang R.M. Peripartum heart failure associated with prolonged tocolytic therapy. Am J Obstet Gynecol 168 2 (1993) 493-495
22. Fett J.D., Ansari A.A., Sundstrom J.B., and Combs G.F. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol 86 2-3 (2002) 311-316
23. Blegen S.D. Post-partum congestive heart failure. Beri-beri heart disease. Acta Med Scand 178 4 (1965) 515-524
24. Cenac A., Simonoff M., and Djibo A. Nutritional status and plasma trace elements in peripartum cardiomyopathy. A comparative study in Niger. J Cardiovasc Risk 3 6 (1996) 483-487
25. Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J 129 2 (1995) 421-422
26. Massad L.S., Reiss C.K., Mutch D.G., and Haskel E.J. Familial peripartum cardiomyopathy after molar pregnancy. Obstet Gynecol 81 5 Pt 2 (1993) 886-888
27. Sanderson J.E., Olsen E.G., and Gatei D. Peripartum heart disease: an endomyocardial biopsy study. Br Heart J 56 3 (1986) 285-291
28. Felker G.M., Jaeger C.J., Klodas E., et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 140 5 (2000) 785-791
29. Felker G.M., Thompson R.E., Hare J.M., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. [see comments]. N Engl J Med 342 15 (2000) 1077-1084
30. Maisch B., Ristic A.D., and Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 23 19 (2002) 1503-1508
31. Ristic A.D., Seferovic P.M., Ljubic A., et al. Pericardial disease in pregnancy. Herz 28 3 (2003) 209-215
32. Maisch B., Lamparter S., Ristic A., and Pankuweit S. Pregnancy and cardiomyopathies. Herz 28 3 (2003) 196-208
33. Farber P.A., and Glasgow L.A. Viral myocarditis during pregnancy: encephalomyocarditis virus infection in mice. Am Heart J 80 1 (1970) 96-102
34. Cenac A., Gaultier Y., Devillechabrolle A., and Moulias R. Enterovirus infection in peripartum cardiomyopathy. Lancet 2 8617 (1988) 968-969
35. Bultmann B.D., Klingel K., Nabauer M., Wallwiener D., and Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193 2 (2005) 363-365
36. Bryant E.E., Douglas B.H., and Ashburn A.D. Circulatory changes following prolactin administration. Am J Obstet Gynecol 115 1 (1973) 53-57
37. Dschietzig T., Richter C., Bartsch C., et al. The pregnancy hormone relaxin is a player in human heart failure. FASEB J 15 12 (2001) 2187-2195
38. Unemori E.N., and Amento E.P. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem 265 18 (1990) 10681-10685
39. Thomas C.V., Coker M.L., Zellner J.L., Handy J.R., Crumbley A.J., and Spinale F.G. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 97 17 (1998) 1708-1715
40. Ansari A.A., Fett J.D., Carraway R.E., Mayne A.E., Onlamoon N., and Sundstrom J.B. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 23 3 (2002) 301-324
41. Sliwa K., Forster O., Libhaber E., et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 27 4 (2006) 441-446
42. Cenac A., Beaufils H., Soumana I., Vetter J.M., Devillechabrolle A., and Moulias R. Absence of humoral autoimmunity in peripartum cardiomyopathy. A comparative study in Niger. Int J Cardiol 26 1 (1990) 49-52
43. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333 5 (1995) 269-275
44. Bozkurt B., Villaneuva F.S., Holubkov R., et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 34 1 (1999) 177-180
45. Elkayam U., Tummala P.P., Rao K., et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344 21 (2001) 1567-1571
46. Horowitz M.S., Schultz C.S., Stinson E.B., Harrison D.C., and Popp R.L. Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation 50 2 (1974) 239-247